These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1237 related items for PubMed ID: 28180961

  • 1. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [Abstract] [Full Text] [Related]

  • 2. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
    Stefani A, Iranzo A, Holzknecht E, Perra D, Bongianni M, Gaig C, Heim B, Serradell M, Sacchetto L, Garrido A, Capaldi S, Sánchez-Gómez A, Cecchini MP, Mariotto S, Ferrari S, Fiorini M, Schmutzhard J, Cocchiara P, Vilaseca I, Brozzetti L, Monaco S, Jose Marti M, Seppi K, Tolosa E, Santamaria J, Högl B, Poewe W, Zanusso G, SINBAR (Sleep Innsbruck Barcelona) group.
    Brain; 2021 May 07; 144(4):1118-1126. PubMed ID: 33855335
    [Abstract] [Full Text] [Related]

  • 3. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K, Doerr Y, Möller JC, Höffken H, Behr TM, Oertel WH, Mayer G.
    Brain; 2005 Jan 07; 128(Pt 1):126-37. PubMed ID: 15548552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility.
    Donadio V, Doppler K, Incensi A, Kuzkina A, Janzen A, Mayer G, Volkmann J, Rizzo G, Antelmi E, Plazzi G, Sommer C, Liguori R, Oertel WH.
    Eur J Neurol; 2019 Oct 07; 26(10):1245-1251. PubMed ID: 30770596
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.
    Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M.
    Neurology; 2018 Sep 04; 91(10):e894-e905. PubMed ID: 30089615
    [Abstract] [Full Text] [Related]

  • 9. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP, Niccoli Asabella A, Iuele F, Stabile Ianora AA, Giganti M, Rubini G.
    Recenti Prog Med; 2012 Nov 04; 103(11):500-4. PubMed ID: 23096739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T, Ikuno M, Hondo M, Parajuli LK, Taguchi K, Ueda J, Sawamura M, Okuda S, Nakanishi E, Hara J, Uemura N, Hatanaka Y, Ayaki T, Matsuzawa S, Tanaka M, El-Agnaf OMA, Koike M, Yanagisawa M, Uemura MT, Yamakado H, Takahashi R.
    Brain; 2020 Jan 01; 143(1):249-265. PubMed ID: 31816026
    [Abstract] [Full Text] [Related]

  • 12. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M, Nikolic M, Biernat H, Korbo L, Friberg L, Jennum P.
    J Clin Sleep Med; 2016 Jun 15; 12(6):895-903. PubMed ID: 27070245
    [Abstract] [Full Text] [Related]

  • 13. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, Kesper K, Adriaanse SM, Booij J, Leenders KL, Oertel WH.
    Mov Disord; 2017 Oct 15; 32(10):1482-1486. PubMed ID: 28734065
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oligomeric Alpha-Synuclein and STX-1A from Neural-Derived Extracellular Vesicles (NDEVs) as Possible Biomarkers of REM Sleep Behavior Disorder in Parkinson's Disease: A Preliminary Cohort Study.
    Meloni M, Agliardi C, Guerini FR, Saibene FL, Milner AV, Zanzottera M, Bolognesi E, Puligheddu M, Figorilli M, Navarro J, Clerici M.
    Int J Mol Sci; 2023 May 16; 24(10):. PubMed ID: 37240185
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A, Santamaría J, Valldeoriola F, Serradell M, Salamero M, Gaig C, Niñerola-Baizán A, Sánchez-Valle R, Lladó A, De Marzi R, Stefani A, Seppi K, Pavia J, Högl B, Poewe W, Tolosa E, Lomeña F.
    Ann Neurol; 2017 Sep 16; 82(3):419-428. PubMed ID: 28833467
    [Abstract] [Full Text] [Related]

  • 18. REM sleep behavior disorder and neuropathology in Parkinson's disease.
    Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG.
    Mov Disord; 2015 Sep 16; 30(10):1413-7. PubMed ID: 26265105
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prodromal Parkinson's disease--using REM sleep behavior disorder as a window.
    Postuma RB.
    Parkinsonism Relat Disord; 2014 Jan 16; 20 Suppl 1():S1-4. PubMed ID: 24262156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.